
News
Home>News & Events>Presentations>CDRC>Using Real World Data from CURE ID to Identify Drug Repurposing Opportunities in Mycology: Impact of Climate Change
Related Posts
-
Newcastle University’s John Walton Muscular Dystrophy Research Centre Contributes Data to C-Path’s RDCA-DAP
-
Shaping the Global Innovation and Access Landscape for Better Paediatric Medicines: C-Path Becomes Official Partner of WHO
-
CACNA1A Foundation to Contribute Data to C-Path’s RDCA-DAP, Accelerating Neurological Disease Research and Therapeutic Development
-
C-Path’s Transplant Therapeutics Consortium’s Work Highlighted in Recent Publication in the American Journal of Transplantation
-
C-Path Welcomes Red Nucleus Clinical